| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |